SE8107292L - 5,5'-azobis-salicylsyra samt farmakologiskt acceptabla salter derav - Google Patents

5,5'-azobis-salicylsyra samt farmakologiskt acceptabla salter derav

Info

Publication number
SE8107292L
SE8107292L SE8107292A SE8107292A SE8107292L SE 8107292 L SE8107292 L SE 8107292L SE 8107292 A SE8107292 A SE 8107292A SE 8107292 A SE8107292 A SE 8107292A SE 8107292 L SE8107292 L SE 8107292L
Authority
SE
Sweden
Prior art keywords
azobis
acceptable salts
salicylic acid
pharmacological acceptable
pharmacological
Prior art date
Application number
SE8107292A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
H J Lambert
B S Pitzele
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of SE8107292L publication Critical patent/SE8107292L/

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B63/00Lakes
    • C09B63/005Metal lakes of dyes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8107292A 1981-03-02 1981-12-07 5,5'-azobis-salicylsyra samt farmakologiskt acceptabla salter derav SE8107292L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/239,813 US4312806A (en) 1981-03-02 1981-03-02 Method and compounds for treating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
SE8107292L true SE8107292L (sv) 1982-09-03

Family

ID=22903854

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8107292A SE8107292L (sv) 1981-03-02 1981-12-07 5,5'-azobis-salicylsyra samt farmakologiskt acceptabla salter derav

Country Status (23)

Country Link
US (1) US4312806A (ja)
JP (1) JPS57144219A (ja)
AT (1) AT375637B (ja)
AU (1) AU545804B2 (ja)
BE (1) BE891583A (ja)
CA (1) CA1167031A (ja)
CH (1) CH647409A5 (ja)
DE (1) DE3149359A1 (ja)
DK (1) DK540581A (ja)
ES (1) ES8500894A1 (ja)
FI (1) FI813919L (ja)
FR (1) FR2500824B1 (ja)
GB (1) GB2093833B (ja)
GR (1) GR76684B (ja)
IE (1) IE52898B1 (ja)
IL (1) IL64459A0 (ja)
IT (1) IT1147821B (ja)
NL (1) NL8105824A (ja)
NO (1) NO153099C (ja)
NZ (1) NZ199273A (ja)
PH (1) PH17040A (ja)
SE (1) SE8107292L (ja)
ZA (1) ZA818507B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
SE8002322L (sv) * 1980-03-26 1981-09-27 Pharmacia Ab Medel for behandling av inflammatoriska tarmsjukdomar
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
SE8303400D0 (sv) * 1983-06-15 1983-06-15 Pharmacia Ab Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning
SE8303399D0 (sv) * 1983-06-15 1983-06-15 Pharmacia Ab Azo-bis-salicyl syra och salt derav, deras farmaceutiska beredning samt framstellning av syran
SE8405924L (sv) * 1984-11-23 1986-05-24 Pharmacia Ab Nya azoforeningar
US5120306A (en) * 1990-03-21 1992-06-09 Gosselin Leon F Direct delivery of anti-inflammatories to the proximal small bowel
ES2104513B1 (es) * 1995-10-11 1998-07-01 Uriach & Cia Sa J Nuevos derivados del acido 5-aminosalicilico.
ES2106682B1 (es) * 1995-09-08 1998-07-01 Uriach & Cia Sa J Nuevos derivados azo del acido 5-aminosalicilico.
US5747477A (en) * 1995-09-08 1998-05-05 J. Uriach & Cia S.A. Azo derivatives of 5-aminosalicylic acid
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
ES2165803B1 (es) 2000-04-10 2003-09-16 Uriach & Cia Sa J Nueva sal de un derivado azo del acido 5-aminosalicilico
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
EP2154157A3 (en) 2004-01-12 2010-04-28 Applied Molecular Evolution Inc. FC region variants
WO2010042933A2 (en) 2008-10-10 2010-04-15 Northwestern University Inhibition and treatment of prostate cancer metastasis
JP2017534627A (ja) 2014-11-06 2017-11-24 ノースウエスタン ユニバーシティNorthwestern University 癌細胞運動性の阻害
CN105985259B (zh) * 2015-02-04 2018-07-27 中国科学院化学研究所 偶氮苯甲酸类化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1157169A (en) * 1914-11-03 1915-10-19 Geigy Ag J R Mordant-dyeing azo dye.
GB408676A (en) * 1931-10-17 1934-04-16 Ig Farbenindustrie Ag The manufacture of symmetrically substituted azobenzene compounds
US2894984A (en) * 1958-05-15 1959-07-14 Pennsalt Chemicals Corp 4-trifluoromethyl salicylic acids and their preparation
US3413225A (en) * 1966-06-27 1968-11-26 Monsanto Co Functional fluid containing azo benzene derivatives as antioxidants
US3674844A (en) * 1970-04-20 1972-07-04 Merck & Co Inc Salicylic acid derivatives
US4190716A (en) * 1978-12-20 1980-02-26 Dynapol Polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
SE8002322L (sv) * 1980-03-26 1981-09-27 Pharmacia Ab Medel for behandling av inflammatoriska tarmsjukdomar

Also Published As

Publication number Publication date
NZ199273A (en) 1985-03-20
US4312806A (en) 1982-01-26
DK540581A (da) 1982-09-03
JPS57144219A (en) 1982-09-06
GR76684B (ja) 1984-08-24
FI813919L (fi) 1982-09-03
IE813104L (en) 1982-09-02
FR2500824A1 (fr) 1982-09-03
GB2093833B (en) 1985-01-23
ZA818507B (en) 1983-07-27
ES507811A0 (es) 1984-11-01
IT1147821B (it) 1986-11-26
GB2093833A (en) 1982-09-08
NO153099C (no) 1986-01-15
CA1167031A (en) 1984-05-08
BE891583A (fr) 1982-06-22
ES8500894A1 (es) 1984-11-01
PH17040A (en) 1984-05-17
DE3149359A1 (de) 1982-09-16
ATA540681A (de) 1984-01-15
IT8247894A0 (it) 1982-03-02
IL64459A0 (en) 1982-03-31
FR2500824B1 (fr) 1985-07-19
AT375637B (de) 1984-08-27
AU7828681A (en) 1982-09-09
NO814424L (no) 1982-09-03
AU545804B2 (en) 1985-08-01
NL8105824A (nl) 1982-10-01
CH647409A5 (de) 1985-01-31
IE52898B1 (en) 1988-04-13
NO153099B (no) 1985-10-07

Similar Documents

Publication Publication Date Title
SE8107292L (sv) 5,5'-azobis-salicylsyra samt farmakologiskt acceptabla salter derav
ES8301632A1 (es) Un metodo, para la preparacion de una formulacion farmaceutica de un agente bioactivo polar.
ES8705865A1 (es) Procedimiento para preparar derivados de becimidazol sustituidos en posicion 5
ES2040242T3 (es) Composiciones farmaceuticas.
ATE29129T1 (de) Hydroxamsaeuren, ihre herstellung und ihre verwendung in pharmazeutischen mitteln.
SE8102220L (sv) Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel
SE8500996D0 (sv) Method of treatment
FR2387230A1 (fr) Nouvelles pyrroloquinoxalines et leurs sels, procede de preparation et application a titre de medicaments
DK619484D0 (da) Farmaceutisk praeparat mod rheumatiske lidelser
PT76196B (fr) Procede de preparation de derives d'imidazolidine et de compositions pharmaceutiques les contenant
KR890012942A (ko) 5-치환된 오르니틴 유도체
EP0228314A3 (en) Use of ethanol/amine derivatives in treating or preventing hyperlipemia
SE8303399D0 (sv) Azo-bis-salicyl syra och salt derav, deras farmaceutiska beredning samt framstellning av syran
EP0030023A3 (en) A heterocyclic compound and its synthesis, pharmaceutical formulations thereof and the use of the compounds and the formulations in medicine
ES2088567T3 (es) Empleo de derivados de la 2-iminotioazolidin-4-ona como nuevos productos activos para medicamentos.
PT78071A (fr) Procede de preparation de nouvelles compositions pharmaceutiques renfermant des derives d'amides des acides mercaptoaceptique et 3-mercaptopropionique
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
EP0383481A3 (en) Anesthetic oral compositions
JPS57134452A (en) N-acyl acidic amino acid diamide, its preparation, and antiulcer agent containing the same
US4243679A (en) S-(3-Methyl-2-butenyl)cysteine
SE8303400D0 (sv) Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning
GB1392241A (en) Antibacterial agents and a process for the preparation thereof
US3928599A (en) Method for treating rheumatoid arthritis
DE2418467C3 (de) Substituierte Benzanilide und Verfahren zu deren Herstellung
FR2483918B1 (fr) Composition anti-inflammatoire contenant a titre de principe actif des derives de l'acide phenyl-acetique ou phenyl-propionique

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8107292-8

Effective date: 19880112